Table 1.
Frequencies of CTLA-4 polymorphisms in melanoma patients and healthy controls
| Controls | Melanomas | ||||
|---|---|---|---|---|---|
| Number (N = 288) | % | Number (N = 286) | % | P | |
| AG 49 | |||||
| A/A | 152 | 52.8 | 132 | 46.2 | 0.27 |
| A/G | 111 | 38.5 | 128 | 44.8 | |
| G/G | 25 | 8.7 | 26 | 9.1 | |
| CT 318 | |||||
| C/C | 230 | 79.9 | 229 | 80.1 | 0.94 |
| C/T | 57 | 19.8 | 55 | 19.2 | |
| T/T | 1 | 0.4 | 2 | 0.7 | |
| CT 60 | |||||
| A/A | 90 | 31.3 | 65 | 22.7 | 0.071 |
| A/G | 135 | 46.9 | 151 | 52.8 | |
| G/G | 63 | 21.9 | 70 | 24.5 | |
| JO 27 | |||||
| C/C | 90 | 31.3 | 73 | 25.5 | 0.32 |
| C/T | 143 | 49.7 | 153 | 53.5 | |
| T/T | 55 | 19.1 | 60 | 21.0 | |
| JO 30 | |||||
| A/A | 95 | 33.0 | 72 | 25.2 | 0.12 |
| A/G | 138 | 47.9 | 151 | 52.8 | |
| G/G | 55 | 19.1 | 63 | 22.0 | |
| JO 31 | |||||
| T/T | 96 | 33.3 | 71 | 24.8 | 0.047 |
| G/T | 144 | 50.0 | 151 | 52.8 | |
| G/G | 48 | 16.8 | 64 | 22.4 | |